The PROMUS ELEMENT PLUS is sold by Boston Scientific in the Coronary Stents – DES market. Drug eluting stents (DES) release drugs locally and can be coated with a polymeric material. The stent ...

According to GlobalData, PROMUS ELEMENT PLUS is one of 45 product lines sold in the US coronary stents market; these product lines are sold by 8 different manufacturers. The price of the PROMUS ...

To enrich the study with women and minorities and allow for comparisons to white men, PLATINUM Diversity (N=1,501) patients were pooled with the Promus-Element Plus Post Approval Study (PE PAS ...

“In this pivotal, noninferiority trial … the Synergy stent proved noninferior to the Promus Element Plus stent for [target lesion failure] at 1 year,” Kereiakes said.

Boston Scientific's ongoing stent patent fight against a smaller rival has taken a turn for the worse in a German court. OrbusNeich can now prevent the Massachusetts medical device giant from ...

Separate data showed less vessel straightening with the Promus Element, which can lead to improved blood flow, according to Boston Scientific. The FDA first approved the Promus Element Plus Stent ...

The FDA first approved the Promus Element Plus Stent System in 2011; Boston Scientific's system earlier picked up CE Mark approval in 2009. The article Boston Scientific Succeeds in Stent Trial ...

The FDA first approved the Promus Element Plus Stent System in 2011; Boston Scientific's system earlier picked up CE Mark approval in 2009.